Clinical Trial Update: Phase I Study of Gimatecan in Patients With Myelodysplastic Syndromes [Phase 1]

View source ↗

Summary

This document reports results from a Phase I study of the camptothecin analog gimatecan in patients with myelodysplastic syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• gimatecan (gimatecan)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Myelodysplastic Syndromes, MDS | Phase 1 | Status: COMPLETED